?token=pk_N6r40FsSTYeUvCEX-vHRYg&size=240&format=webp&fallback=404){kind=logo}
Genovis AB (publ.), headquartered in Sweden, is a pioneering biotechnology company that has been at the forefront of the life sciences industry since its founding in 2001. With a strong focus on developing innovative tools for biopharmaceutical research, Genovis operates primarily in Europe and North America, catering to a global clientele.
The company is renowned for its unique enzyme technologies that facilitate the analysis and characterisation of biopharmaceuticals, particularly monoclonal antibodies. Genovis's core products, including its proprietary GlycoConnect™ and FabRICATOR™ platforms, stand out for their ability to streamline workflows and enhance the accuracy of protein analysis.
With a commitment to advancing biotherapeutics, Genovis has established a solid market position, recognised for its contributions to the field and its ongoing innovation in enzyme development.
-17 vs industry average
Genovis AB (publ.)’s score of 21 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Genovis AB (publ.)?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Genovis AB (publ.) yet.
Genovis AB (publ.)'s reported carbon emissions
Genovis AB (publ.), headquartered in Sweden, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Genovis AB may not yet have established formal climate initiatives or targets, which is increasingly common in the biotechnology sector as companies assess their environmental impact.
As the industry moves towards greater transparency and accountability regarding carbon emissions, it is essential for organisations like Genovis AB to consider developing and communicating their climate strategies to align with global sustainability goals.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Genovis AB (publ.)’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Genovis AB (publ.) yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Genovis AB (publ.)
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project